NASDAQ · MADFX
Matrix Advisors Dividend Fund
$40.68+$0.56 (+1.4%)
Matrix Advisors Dividend Fund’s quoted price sits in the upper half of its reported 52-week range, 0.05% below the high.
Loading market information…
NASDAQ · LOGSX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:10 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Live Oak Health Sciences Fund’s quoted price sits in the upper half of its reported 52-week range, 0.04% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Live Oak Health Sciences Fund’s forward annual dividend is $0.49 per share, paid annual. The forward yield is 1.77% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This fund primarily invests in the common stock of companies operating within the healthcare, medical, or life sciences fields. These businesses are typically involved in the research, development, manufacturing, or distribution of related products and services. Under normal market conditions, a minimum of 80% of the fund's net assets will be dedicated to equity investments in such health science enterprises. While the portfolio's main emphasis is on U.S. company common stocks, it retains the option to a lesser degree to include equity REITs, foreign company shares, and American Depositary Receipts, provided these investments meet the fund's established criteria.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:16 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$40.68+$0.56 (+1.4%)
Matrix Advisors Dividend Fund’s quoted price sits in the upper half of its reported 52-week range, 0.05% below the high.
$12.61+$0.06 (+0.48%)
AMF Large Cap Equity Fund’s quoted price sits in the upper half of its reported 52-week range, 1.71% below the high.
$13.14$0.00 (0.0%)
Value Line Core Bond Fund’s quoted price sits in the upper half of its reported 52-week range, 0.98% below the high.
$13.53+$0.02 (+0.15%)
WesMark Tactical Opportunity Fund’s quoted price sits in the upper half of its reported 52-week range, 2.94% below the high.
$39.89-$0.18 (-0.45%)
Nuveen Large Cap Select Fund Class C’s quoted price sits in the upper half of its reported 52-week range, 4.46% below the high.
$12.16+$0.01 (+0.08%)
T. Rowe Price Target Retirement 2005 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.46% below the high.
$57.39-$0.07 (-0.12%)
Paradigm Value Fund’s quoted price sits in the upper half of its reported 52-week range, 10.12% below the high.
$20.26-$0.35 (-1.7%)
Monetta Young Investor Growth Fund’s quoted price sits in the upper half of its reported 52-week range, 10.43% below the high.
